How Robots Are Introducing A New Dimension To Healthcare Service Delivery

Musculoskeletal

Pfizer hit by DMD delay & halts BCMA trial...

Pfizer suffers a DMD delay and halts BCMA trials amid safety woes  Pfizer has paused after seeing three cases of peripheral neuropathy in an early-stage study, enrollment in a critical analysi...

May 06, 2021

osteoporosis-symptoms-risk-factors-diagnosis-and-treatment-options
How Is Osteoporosis Impacting The Quality Of Life?

Osteoporosis is a significant health burden worldwide and associated with pain and decreased physical, social, and mental well-being. The affected person experiences prolonged immobilisation and limited daily activities, which deteriorates the quality of life. At the economic level, fractures due to osteoporosis re...

Find More
recent-pharma-news-update
MedTech Industry Roars Back as FDA Approvals Soar

Zimmer Biomet Receives FDA Approval for its Rosa System On 20 April 2021, Zimmer Biomet received FDA 510(k) clearance for its Rosa Partial Knee system for robotically-assisted partial knee replacement surgeries. This is the new edition to Zimmer Biomet's Rosa Robotics platform, which comprises the Rosa Knee syst...

Find More
chimeric-antigen-receptor-therapies-in-blood-cancers
A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in Blood Cancers

Chimeric Antigen Receptor (CAR) Therapies have changed the treatment paradigm of hematological malignancies to a vast extent. These personalized therapies have not only evolved as a game-changer in the field of medicine but also in the lives of the patients. Until the last approvals made by Novartis and Kite Pha...

Find More

More Views & Analysis

Latest-biotech-pharma-news-updates-for-ajinomot-pfizer-ikena-lilly-bright-peak
Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing

Bright Peak Therapeutics, Ajinomoto Collaborates to Create Novel Immunocytokines Bright Peak Therapeutics has announced a research and licensing collaboration with Ajinomoto to incorporate AJICAP,  Ajinomoto Co.’s proprietary site-specific bioconjugation technology, for the development of Bright Peak Immuno...

Find More

Chronic Pain Market Landscape | Chronic Pain Pipeline | Osteoarthritis
Emerging Therapies in the Chronic Pain Pipeline Transforming the Chronic Pain Market Landscape

More than 100 million people are living with one or the other form of Chronic Pain in the USA, says the Institute of Medicine. The available treatments to tackle cancer, as well as non-cancer pain, include nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, opioids, or combinations of opioids and non-narc...

Find More

robot-robotics-in-healthcare-medical-sector-benefits-disadvantages-and-future-scope-applications-uses
How Robots Are Introducing A New Dimension To Healthcare Service Delivery

Artificial intelligence and robotics are the two technologies that have shown the potential to address and provide solutions to many contemporary issues. The manufacturing sector has been using robotics for quite a long time. However, over the past three-four decades, robots are in use in other sectors as well, suc...

Find More

Hallux-Valgus-market-therapeutics-therapies-epidemiology-pipeline
A Need for Curative Treatment Expected to Attract the Pharma Players in the Hallux Valgus Market Landscape

Hallux Valgus, also know as Bunion, is the most common forefoot problem in adults. It is the most common pathologic entity of the big toe. It refers to the progressive swelling of the soft tissue.  Hallux valgus has been reported to affect approximately 23% of the adult population aged 18 to 65 years global...

Find More

Parkinson’s Disease Cure and Treatment
Parkinson’s Disease: How close are we to a cure?

Neurological disorders are the leading source of disability globally, and Parkinson's is the fastest-growing neurological condition. It could be due to several factors ranging from an increase in geriatric population, longevity, improved diagnostics methodologies, a better understanding of the disease to the specif...

Find More

recent-pharma-news-and-updates-for-santhera-merck-novartis-scribe
Santhera flunks DMD phase 3; Scribe emerges with $20 M; Merck sells off Osteoarthritis drug to Novartis; Research updates on flu vaccine and glioblastoma

Designing a universal flu vaccine by focusing on the immune system  A universal flu vaccine that can foster protection to people against any influenza strain is considered a goal in flu research as it could spare scientists from the often erroneous process of predicting the circulating strains each year and...

Find More

The convergence of technologies and the increasing integration of medical devices to computer networ.....

Find More

Soft Tissue Sarcoma (STS) tumors constitute 1% of all the malignancies. These are rare neoplasms tha.....

Find More

Myocardial infarction (MI), colloquially known as “heart attack” is caused by decreased or compl.....

Find More

Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the immune system of the body mist.....

Find More

Cachexia is a complicated metabolic syndrome related to underlying illness and characterized by musc.....

Find More

An autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythemat.....

Find More